Gilead Sciences

Liver Diseases

Gilead SciencesGilead R&D has helped transform the treatment of chronic hepatitis C infection and help manage chronic hepatitis B infection. The company’s liver disease research focuses on medicines for nonalcoholic steatohepatitis (NASH) in patients with advanced fibrosis and on the long-term suppression of hepatitis B virus.

Products Include Harvoni and Sovaldi

Visit us online

Tags:

©2025 HepFree.NYC. All rights reserved. Site by Lookit®

Log in with your credentials

Forgot your details?